Logo image of SNX

TD SYNNEX CORP (SNX) Stock Fundamental Analysis

USA - NYSE:SNX - US87162W1009 - Common Stock

164.305 USD
+0.56 (+0.34%)
Last: 10/1/2025, 10:23:50 AM
Fundamental Rating

4

Taking everything into account, SNX scores 4 out of 10 in our fundamental rating. SNX was compared to 124 industry peers in the Electronic Equipment, Instruments & Components industry. SNX has a medium profitability rating, but doesn't score so well on its financial health evaluation. SNX has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

SNX had positive earnings in the past year.
In the past year SNX had a positive cash flow from operations.
In the past 5 years SNX has always been profitable.
Of the past 5 years SNX 4 years had a positive operating cash flow.
SNX Yearly Net Income VS EBIT VS OCF VS FCFSNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

SNX has a Return On Assets (2.43%) which is comparable to the rest of the industry.
SNX's Return On Equity of 9.10% is fine compared to the rest of the industry. SNX outperforms 71.77% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.36%, SNX is in the better half of the industry, outperforming 78.23% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SNX is in line with the industry average of 9.48%.
The last Return On Invested Capital (8.36%) for SNX is above the 3 year average (7.79%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.43%
ROE 9.1%
ROIC 8.36%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)8.05%
ROE(5y)8.23%
ROIC(3y)7.79%
ROIC(5y)7.32%
SNX Yearly ROA, ROE, ROICSNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

SNX has a Profit Margin (1.26%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SNX has declined.
SNX has a Operating Margin (2.21%) which is comparable to the rest of the industry.
SNX's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 6.91%, SNX is doing worse than 87.10% of the companies in the same industry.
In the last couple of years the Gross Margin of SNX has declined.
Industry RankSector Rank
OM 2.21%
PM (TTM) 1.26%
GM 6.91%
OM growth 3Y-2.36%
OM growth 5Y-10.29%
PM growth 3Y-1.88%
PM growth 5Y-10.96%
GM growth 3Y4.45%
GM growth 5Y-11%
SNX Yearly Profit, Operating, Gross MarginsSNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SNX is destroying value.
SNX has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SNX has been increased compared to 5 years ago.
SNX has a better debt/assets ratio than last year.
SNX Yearly Shares OutstandingSNX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
SNX Yearly Total Debt VS Total AssetsSNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

SNX has an Altman-Z score of 2.70. This is not the best score and indicates that SNX is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SNX (2.70) is worse than 63.71% of its industry peers.
The Debt to FCF ratio of SNX is 8.83, which is on the high side as it means it would take SNX, 8.83 years of fcf income to pay off all of its debts.
SNX's Debt to FCF ratio of 8.83 is in line compared to the rest of the industry. SNX outperforms 54.03% of its industry peers.
A Debt/Equity ratio of 0.36 indicates that SNX is not too dependend on debt financing.
SNX has a Debt to Equity ratio of 0.36. This is comparable to the rest of the industry: SNX outperforms 40.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 8.83
Altman-Z 2.7
ROIC/WACC0.84
WACC9.95%
SNX Yearly LT Debt VS Equity VS FCFSNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

A Current Ratio of 1.20 indicates that SNX should not have too much problems paying its short term obligations.
The Current ratio of SNX (1.20) is worse than 87.10% of its industry peers.
SNX has a Quick Ratio of 1.20. This is a bad value and indicates that SNX is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SNX (0.71) is worse than 90.32% of its industry peers.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.71
SNX Yearly Current Assets VS Current LiabilitesSNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

4

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 6.40% over the past year.
The Earnings Per Share has been decreasing by -2.52% on average over the past years.
Looking at the last year, SNX shows a small growth in Revenue. The Revenue has grown by 6.94% in the last year.
The Revenue has been growing by 19.73% on average over the past years. This is quite good.
EPS 1Y (TTM)6.4%
EPS 3Y9.13%
EPS 5Y-2.52%
EPS Q2Q%25.17%
Revenue 1Y (TTM)6.94%
Revenue growth 3Y22.74%
Revenue growth 5Y19.73%
Sales Q2Q%6.58%

3.2 Future

The Earnings Per Share is expected to grow by 10.31% on average over the next years. This is quite good.
The Revenue is expected to grow by 4.48% on average over the next years.
EPS Next Y5.26%
EPS Next 2Y8.72%
EPS Next 3Y10.31%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y4.44%
Revenue Next 3Y4.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SNX Yearly Revenue VS EstimatesSNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
SNX Yearly EPS VS EstimatesSNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 13.19, which indicates a correct valuation of SNX.
94.35% of the companies in the same industry are more expensive than SNX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.76. SNX is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 11.91 indicates a reasonable valuation of SNX.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SNX indicates a rather cheap valuation: SNX is cheaper than 92.74% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.18, SNX is valued a bit cheaper.
Industry RankSector Rank
PE 13.19
Fwd PE 11.91
SNX Price Earnings VS Forward Price EarningsSNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

89.52% of the companies in the same industry are more expensive than SNX, based on the Enterprise Value to EBITDA ratio.
SNX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SNX is cheaper than 76.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 28.22
EV/EBITDA 9.6
SNX Per share dataSNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.51
PEG (5Y)N/A
EPS Next 2Y8.72%
EPS Next 3Y10.31%

6

5. Dividend

5.1 Amount

SNX has a Yearly Dividend Yield of 1.06%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.15, SNX pays a better dividend. On top of this SNX pays more dividend than 86.29% of the companies listed in the same industry.
With a Dividend Yield of 1.06, SNX pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.06%

5.2 History

The dividend of SNX has a limited annual growth rate of 1.30%.
SNX has paid a dividend for at least 10 years, which is a reliable track record.
SNX has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.3%
Div Incr Years4
Div Non Decr Years4
SNX Yearly Dividends per shareSNX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

SNX pays out 18.78% of its income as dividend. This is a sustainable payout ratio.
SNX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP18.78%
EPS Next 2Y8.72%
EPS Next 3Y10.31%
SNX Yearly Income VS Free CF VS DividendSNX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B
SNX Dividend Payout.SNX Dividend Payout, showing the Payout Ratio.SNX Dividend Payout.PayoutRetained Earnings

TD SYNNEX CORP

NYSE:SNX (10/1/2025, 10:23:50 AM)

164.305

+0.56 (+0.34%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-25 2025-09-25/bmo
Earnings (Next)01-08 2026-01-08/amc
Inst Owners93.62%
Inst Owner Change-0.68%
Ins Owners0.73%
Ins Owner Change0.16%
Market Cap13.55B
Analysts82.35
Price Target170.8 (3.95%)
Short Float %3.06%
Short Ratio3.44
Dividend
Industry RankSector Rank
Dividend Yield 1.06%
Yearly Dividend1.6
Dividend Growth(5Y)1.3%
DP18.78%
Div Incr Years4
Div Non Decr Years4
Ex-Date10-17 2025-10-17 (0.44)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.7%
Min EPS beat(2)9.03%
Max EPS beat(2)16.37%
EPS beat(4)3
Avg EPS beat(4)5.29%
Min EPS beat(4)-4.6%
Max EPS beat(4)16.37%
EPS beat(8)6
Avg EPS beat(8)4.76%
EPS beat(12)9
Avg EPS beat(12)5.21%
EPS beat(16)12
Avg EPS beat(16)4.97%
Revenue beat(2)2
Avg Revenue beat(2)2.97%
Min Revenue beat(2)2.55%
Max Revenue beat(2)3.39%
Revenue beat(4)3
Avg Revenue beat(4)1.57%
Min Revenue beat(4)-2.72%
Max Revenue beat(4)3.39%
Revenue beat(8)4
Avg Revenue beat(8)0.27%
Revenue beat(12)5
Avg Revenue beat(12)-0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.14%
PT rev (1m)1.18%
PT rev (3m)14.61%
EPS NQ rev (1m)0.03%
EPS NQ rev (3m)3.2%
EPS NY rev (1m)0.12%
EPS NY rev (3m)3.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.67%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.29%
Valuation
Industry RankSector Rank
PE 13.19
Fwd PE 11.91
P/S 0.22
P/FCF 28.22
P/OCF 21.4
P/B 1.6
P/tB 29.33
EV/EBITDA 9.6
EPS(TTM)12.46
EY7.58%
EPS(NY)13.79
Fwd EY8.39%
FCF(TTM)5.82
FCFY3.54%
OCF(TTM)7.68
OCFY4.67%
SpS739.34
BVpS102.51
TBVpS5.6
PEG (NY)2.51
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.43%
ROE 9.1%
ROCE 10.52%
ROIC 8.36%
ROICexc 8.97%
ROICexgc 27.18%
OM 2.21%
PM (TTM) 1.26%
GM 6.91%
FCFM 0.79%
ROA(3y)2.18%
ROA(5y)2.37%
ROE(3y)8.05%
ROE(5y)8.23%
ROIC(3y)7.79%
ROIC(5y)7.32%
ROICexc(3y)8.36%
ROICexc(5y)8.17%
ROICexgc(3y)25.16%
ROICexgc(5y)22.93%
ROCE(3y)9.8%
ROCE(5y)9.21%
ROICexcg growth 3Y14.05%
ROICexcg growth 5Y3.33%
ROICexc growth 3Y21.3%
ROICexc growth 5Y-3.93%
OM growth 3Y-2.36%
OM growth 5Y-10.29%
PM growth 3Y-1.88%
PM growth 5Y-10.96%
GM growth 3Y4.45%
GM growth 5Y-11%
F-Score5
Asset Turnover1.92
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 8.83
Debt/EBITDA 1.73
Cap/Depr 37.19%
Cap/Sales 0.25%
Interest Coverage 250
Cash Conversion 36.03%
Profit Quality 62.43%
Current Ratio 1.2
Quick Ratio 0.71
Altman-Z 2.7
F-Score5
WACC9.95%
ROIC/WACC0.84
Cap/Depr(3y)34.7%
Cap/Depr(5y)39.65%
Cap/Sales(3y)0.25%
Cap/Sales(5y)0.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.4%
EPS 3Y9.13%
EPS 5Y-2.52%
EPS Q2Q%25.17%
EPS Next Y5.26%
EPS Next 2Y8.72%
EPS Next 3Y10.31%
EPS Next 5YN/A
Revenue 1Y (TTM)6.94%
Revenue growth 3Y22.74%
Revenue growth 5Y19.73%
Sales Q2Q%6.58%
Revenue Next Year4.74%
Revenue Next 2Y4.44%
Revenue Next 3Y4.48%
Revenue Next 5YN/A
EBIT growth 1Y5.75%
EBIT growth 3Y19.84%
EBIT growth 5Y7.42%
EBIT Next Year13.49%
EBIT Next 3Y8.63%
EBIT Next 5YN/A
FCF growth 1Y-64.51%
FCF growth 3Y11.36%
FCF growth 5Y20.38%
OCF growth 1Y-57.75%
OCF growth 3Y14.57%
OCF growth 5Y17.23%